Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Southeastern Gynecologic Oncology
With
Current best practice recommends Carboplatin combined with Taxol in the treatment of Ovarian cancer. Taxol is paclitaxel in the solvent Cremophor-El and the solvent has been associated with significant side effects e.g. anaphylaxis and hypersensitivity. this requires the routine use of premedication with antihistamines and steroids. Abraxane by contrast is Cremophor-El free and is protein bound. This has 2 advantages over Taxol. 1. No need for routine premedications 2. Increased drug entry into cells facilitating greater potential for anti-tumor activity. Schedule: Carboplatin day1 every 28days. Abraxane day1,8,15 every 28days.
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted